Study 102 was con ducted with n erati nib being supplied as 10 mg and 40 mg capsules. Neratinib was taken orally once daily in the morning with food. Subjects initially received a single dose of the test article, followed by a 1-week observation period, during which PK samples were collected and AEs were monitored. One week after the single dose, the same dose level of neratinib was administered orally once daily in the morning with food.